KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia.

Yu Nakamura, Jun Adachi, Naoki Hirota, Katsuhiro Iba, Cosmo Sasajima, Koichi Shimizu, Masami Nakai, Kaneyoshi Takahashi

Alzheimers Dement 21(7) e70522

PMID40717666
PMCIDPMC12301695
DOI10.1002/alz.70522
发表日期2025-07-28
入排依据:未发现恶性肿瘤人群证据。
已检查 4 张 PubMed Figure,均未识别为 KM 图:FIGURE 1:AI 判定为 other;FIGURE 2:AI 判定为 other;FIGURE 3:AI 判定为 other;FIGURE 4:AI 判定为 other。
摘要

摘要

INTRODUCTION: We evaluated the impacts of brexpiprazole treatment on patient neuropsychiatric symptoms and caregiver distress in Japanese patients with agitation in Alzheimer's dementia (AAD). METHODS: In a phase 2/3 multicenter, double-blind study, patients were randomized to receive brexpiprazole 1 or 2 mg/day, or placebo (3:4:4) for 10 weeks. The Neuropsychiatric Inventory (NPI) was used for evaluation. The areas of patient symptoms and caregiver distress were defined as NPI and NPI-Distress, respectively. RESULTS: At Week 10, the differences of brexpiprazole 1 and 2 mg versus placebo for NPI total score were -1.2 (p = 0.5891) and -8.4 (p < 0.0001), and those for NPI-Distress total score were -1.1 (p = 0.2292) and -3.9 (p < 0.0001), respectively. In brexpiprazole 2 mg versus placebo, NPI and NPI-Distress agitation/aggression score showed ≥ 2 and ≥ 1 point improvement, respectively. DISCUSSION: Brexpiprazole is suggested to improve patient symptoms and to reduce caregiver distress in the treatment of AAD in Japanese patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT03620981 HIGHLIGHTS: Brexpiprazole improved symptoms of patients with agitation in Alzheimer's dementia. The improvements included not only agitation, but also various behavioral and psychological symptoms of dementia scores. The improvements of patient symptoms led to the reduction of caregiver distress. Our study suggests that brexpiprazole is beneficial for both patients and caregivers.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(4,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

FIGURE 1FIGURE 1 Time course of NPI and NPI‐Distress total scores (FAS). MMRM analysis. * p < 0.05, ** p < 0.01, *** p < 0.001. FAS, full analysis set; LS, least squares; MMRM, mixed models for repeated measures; NPI, Neuropsychiatric Inventory; NPI‐Distress, Neuropsychiatric Inventory‐Distress; SE, standard error.
非 KM Figure
FIGURE 2FIGURE 2 Time course of NPI and NPI‐Distress individual scores (agitation/aggression) (FAS). MMRM analysis. *** p < 0.001. FAS, full analysis set; LS, least squares; MMRM, mixed models for repeated measures; NPI, Neuropsychiatric Inventory; NPI‐Distress, Neuropsychiatric Inventory‐Distress; SE, standard error.
非 KM Figure
FIGURE 3FIGURE 3 Changes in NPI individual scores from baseline to Week 10 (FAS). MMRM analysis. * p < 0.05, ** p < 0.01, *** p < 0.001. BL, baseline; FAS, full analysis set; LS, least squares; MMRM, mixed models for repeated measures; NPI, Neuropsychiatric Inventory; SE, standard error.
非 KM Figure
FIGURE 4FIGURE 4 Changes in NPI‐Distress individual scores from baseline to Week 10 (FAS). MMRM analysis. * p < 0.05, ** p < 0.01, *** p < 0.001. BL, baseline; FAS, full analysis set; LS, least squares; MMRM, mixed models for repeated measures; NPI‐Distress, Neuropsychiatric Inventory Distress; SE, standard error.
非 KM Figure